Company intelligence / Profile preview

A2Z Bio

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

A2Z Bio is an early-stage biotechnology company focused on developing innovative molecular diagnostic solutions. The company leverages a proprietary platform designed to provide rapid, accurate, and cost-effective testing for a variety of clinical applications, including infectious diseases and oncology. By streamlining the diagnostic workflow, A2Z Bio aims to improve patient outcomes through earlier detection and more informed treatment decisions. The company is currently advancing its technology through the pre-clinical development phase while seeking strategic partnerships to scale its diagnostic capabilities.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Diagnostic testMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on A2Z Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A2Z Bio.

Explore the full profile